Elsevier

Behavior Therapy

Volume 50, Issue 1, January 2019, Pages 165-176
Behavior Therapy

Predictors and Moderators of Cognitive and Behavioral Therapy Outcomes for OCD: A Patient-Level Mega-Analysis of Eight Sites,☆☆

https://doi.org/10.1016/j.beth.2018.04.004Get rights and content

Highlights

  • Behavior therapy, cognitive therapy and their combination showed benefits for OCD and depression

  • Improvements in OCD symptoms were somewhat greater for treatments containing cognitive therapy

  • Lower initial depression predicted more benefit, especially for behavior therapy

  • Stronger beliefs about responsibility and harm and more education may influence cognitive therapy benefits

  • Medication status and comorbidity did not predict treatment outcome.

Abstract

Cognitive (CT) and behavioral treatments (BT) for OCD are efficacious separately and in combination. Tailoring treatment to patient-level predictors and moderators of outcome has the potential to improve outcomes. The present study combined data from eight treatment clinics to examine the benefits of BT (n = 125), CT (n = 108), and CBT (n = 126), and study predictors across all treatments and moderators of outcome by treatment type. All three methods led to large benefits for OCD and depression symptoms. Residual gain scores for OCD symptoms were marginally smaller for BT compared to treatments containing CT. For depression, significantly more gains were evident for CBT than BT, and CT did not differ from either. Significantly fewer BT participants (36%) achieved clinically significant improvement compared to CT (56%), and this was marginally evident for CBT (48%). For all treatments combined, no predictors were identified in residual gain analyses, but clinically improved patients had lower baseline depression and stronger beliefs about responsibility/threat and importance/control of thoughts. Moderator analyses indicated that higher baseline scores on depression adversely affected outcomes for BT but not CT or CBT, and lower OCD severity and more education were associated with positive outcomes for CT only. A trend was evident for higher responsibility/threat beliefs to moderate clinical improvement outcomes for those receiving cognitive (CT and CBT), but not behavioral (BT) treatment. Medication status and comorbidity did not predict or moderate outcomes. Findings are discussed in light of models underlying behavioral and cognitive treatments for OCD.

Section snippets

Design and Sample

Pre- and posttreatment data were collected from eight participating research clinic centers that studied cognitive and behavioral treatments alone and/or in combination for outpatients diagnosed with OCD. Sites were chosen because they used similar manualized treatment procedures and identical outcome measures. Investigators could include data from participants treated in research trials and/or in outpatient clinic settings that employed comparable assessment and treatment protocols.

Sample Characteristics

Analyses included 359 participants of whom 125 received BT, 108 received CT, and 126 received CBT. Table 1 provides demographic information and descriptive statistics for the three treatment types and the eight different sites. Of 242 (67%) participants for whom race/ethnicity data were available, a large majority were Caucasian (91%, n = 221). Of the 324 (90%) participants whose marital status was known, 147 (45%) were married or cohabitating, 144 (44%) were single and never married, and 33

Discussion

The primary purpose of this study was to identify predictors of treatment response across interventions for OCD as well as moderators for BT, CT, and CBT using data from eight treatment clinics. Combining sites increased the sample size and appeared justified by the generally similar demographic features, with few exceptions. Baseline severity of OCD, depression and beliefs was also comparable across sites, with only one site (Cottraux) reporting higher Y-BOCS scores. Treatment outcomes were

Conflict of Interest Statement

The authors of the paper submit the following information about potential conflicts of interest:

Gail Steketee: Dr. Steketee was Co-PI on a grant funded by the International OCD Foundation (IOCDF) to Dr. Sabine Wilhelm to support this project. The funding enabled us to employ research assistants to gather and analyze the data. I am not aware of any specific bias with regard to outcomes due to the source of funding. She has received royalties from Elsevier Publications, Guilford Publications, New

References (40)

  • G. Steketee et al.

    Methodological issues in predicting treatment outcome

    Clinical Psychology Review

    (1992)
  • G. Steketee et al.

    Effects of axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia

    Comprehensive Psychiatry

    (2001)
  • G. Steketee et al.

    The Yale-Brown Obsessive Compulsive Scale: Interview versus self-report

    Behaviour Research and Therapy

    (1996)
  • S.R. Woody et al.

    Reliability and validity of the Yale-Brown Obsessive–Compulsive Scale

    Behaviour Research and Therapy

    (1995)
  • J.S. Abramowitz

    Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review

    Journal of Consulting and Clinical Psychology

    (1997)
  • American Psychiatric Association

    Diagnostic and statistical manual of mental disorders

    (1994)
  • A.T. Beck et al.

    Cognitive therapy of depression

    (1979)
  • T.A. Brown et al.

    Anxiety disorders interview Schedule for DSM-IV: Adult version

    (1994)
  • D.J. Castle et al.

    Obsessive-compulsive disorder: Prediction of outcome from behavioural psychotherapy

    Acta Psychiatrica Scandinavica

    (1994)
  • J. Cottraux et al.

    A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder

    Psychotherapy and Psychosomatics

    (2001)
  • Cited by (46)

    • Psychotherapies and digital interventions for OCD in adults: What do we know, what do we need still to explore?

      2023, Comprehensive Psychiatry
      Citation Excerpt :

      As stated above, ERP, CBT and CT are all highly effective. Steketee et al.'s [19] mega-analysis of RCTs and clinical studies showed large effect sizes for CBT, CT and ERP for OCD and depression symptom reduction. However, OCD symptom severity decreases were slightly smaller for ERP in comparison to treatments that incorporated CT.

    View all citing articles on Scopus

    This study was supported by a grant from the International OCD Foundation awarded to Dr. Wilhelm. The authors are grateful to the following colleagues who provided data for this study: Dr. Jonathan Abramowitz, Dr. Jean Cottraux, Dr. Michael Kyrios, Dr. Kieron O’Connor, Dr. Neil Rector, Dr. David Tolin, Dr. Maureen Whittal, and Dr. Sabine Wilhelm.

    ☆☆

    Data statement. All data files were shared with permission of the investigators of the 8 research sites, following IRB regulations regarding protection of human subjects. We do not have permission to share these data files with other investigators.

    View full text